Rabbit anti-Mouse Cathepsin A Polyclonal Antibody | anti-CTSA antibody
Anti-Cathepsin A Antibody, Rabbit Polyclonal
ELISA: 1:5000-1:10,000
IP: 4-6uL/mg of lysate
Immunoprecipitation (IP)
(Mouse CTSA was immunoprecipitated using:Lane A:0.5 mg K562 Whole Cell LysateLane B:0.5 mg A549 Whole Cell Lysate2 uL anti-Mouse CTSA rabbit polyclonal antibody and 15 ul of 50 % Protein G agarose.Primary antibody:Anti-Mouse CTSA rabbit polyclonal antibody,at 1:100 dilution Secondary antibody:Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution Developed using the odssey technique.Performed under reducing conditions.Predicted band size: 30 kDaObserved band size: 30 kDa)
Western Blot (WB)
(Anti-CTSA rabbit polyclonal antibody at 1:500 dilutionLane A: Hela Whole Cell LysateLane B: HepG2 Whole Cell LysateLysates/proteins at 30 ug per lane.SecondaryGoat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution.Developed using the Odyssey technique. Performed under reducing conditions.Predicted band size:30 kDaObserved band size:28 kDa)
NCBI and Uniprot Product Information
NCBI Description
This gene encodes a glycoprotein with deamidase, esterase and carboxypeptidase activities. The encoded protein associates with and provides a protective function to the lysosomal enzymes beta-galactosidase and neuraminidase. Deficiency of the related gene in humans results in galactosialidosis. The proprotein is processed into two shorter chains. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2013]
Uniprot Description
CTSA: Protective protein appears to be essential for both the activity of beta-galactosidase and neuraminidase, it associates with these enzymes and exerts a protective function necessary for their stability and activity. This protein is also a carboxypeptidase and can deamidate tachykinins. Defects in CTSA are the cause of galactosialidosis (GSL). A lysosomal storage disease associated with a combined deficiency of beta-galactosidase and neuraminidase, secondary to a defect in cathepsin A. All patients have clinical manifestations typical of a lysosomal disorder, such as coarse facies, cherry red spots, vertebral changes, foam cells in the bone marrow, and vacuolated lymphocytes. Three phenotypic subtypes are recognized. The early infantile form is associated with fetal hydrops, edema, ascites, visceromegaly, skeletal dysplasia, and early death. The late infantile type is characterized by hepatosplenomegaly, growth retardation, cardiac involvement, and a normal or mildly affected mental state. The juvenile/adult form is characterized by myoclonus, ataxia, angiokeratoma, mental retardation, neurologic deterioration, absence of visceromegaly, and long survival. Belongs to the peptidase S10 family.
Protein type: EC 3.4.16.5; Endoplasmic reticulum; Mitochondrial; Protease
Chromosomal Location of Human Ortholog: 2 H3|2 85.27 cM
Cellular Component: intracellular membrane-bound organelle; lysosomal membrane; membrane; mitochondrion; nucleoplasm
Molecular Function: glycoprotein binding; protein binding; serine carboxypeptidase activity
Biological Process: proteolysis; proteolysis involved in cellular protein catabolic process; regulation of protein stability